The Ensign Group (NASDAQ:ENSG) issued an update on its FY17 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.80-1.87 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.40. The company issued revenue guidance of $2-2.06 billion, compared to the consensus revenue estimate of $1.80 billion.
The Ensign Group (NASDAQ ENSG) traded down $0.06 during mid-day trading on Thursday, hitting $23.57. 352,074 shares of the company were exchanged, compared to its average volume of 215,296. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.53 and a current ratio of 1.53. The Ensign Group has a 1-year low of $16.50 and a 1-year high of $24.78. The firm has a market cap of $1,175.90, a PE ratio of 26.19 and a beta of 0.81.
The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Wednesday, November 8th. The company reported $0.33 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.35 by ($0.02). The Ensign Group had a return on equity of 13.15% and a net margin of 2.65%. The firm had revenue of $471.59 million during the quarter, compared to analyst estimates of $445.95 million. analysts expect that The Ensign Group will post 1.28 earnings per share for the current fiscal year.
A number of equities analysts recently issued reports on ENSG shares. Royal Bank of Canada increased their target price on shares of The Ensign Group to $27.00 and gave the company an outperform rating in a research report on Monday, November 20th. ValuEngine lowered shares of The Ensign Group from a buy rating to a hold rating in a research report on Tuesday, November 14th. BidaskClub lowered shares of The Ensign Group from a buy rating to a hold rating in a research report on Tuesday, December 5th. Finally, Cantor Fitzgerald increased their target price on shares of The Ensign Group from $23.00 to $27.00 and gave the company an overweight rating in a research report on Thursday, November 9th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of $26.67.
In other news, VP Beverly B. Wittekind sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $22.55, for a total transaction of $112,750.00. Following the completion of the transaction, the vice president now owns 46,656 shares in the company, valued at approximately $1,052,092.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Barry Port sold 5,901 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $24.11, for a total transaction of $142,273.11. Following the transaction, the vice president now owns 125,584 shares of the company’s stock, valued at approximately $3,027,830.24. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 69,318 shares of company stock valued at $1,648,075. Insiders own 6.20% of the company’s stock.
About The Ensign Group
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.